Home Cart Sign in  
Chemical Structure| 515-03-7 Chemical Structure| 515-03-7

Structure of Sclareol
CAS No.: 515-03-7

Chemical Structure| 515-03-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sclareol is a naturally occuring fragrant chemical compound found in clary sage, used as a fragrance in cosmetics and perfumes and as flavoring in food.

Synonyms: (–)-Sclareol

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sclareol

CAS No. :515-03-7
Formula : C20H36O2
M.W : 308.50
SMILES Code : C[C@]12[C@@](C(C)(CCC2)C)([H])CC[C@@](O)([C@@H]1CC[C@@](C)(O)C=C)C
Synonyms :
(–)-Sclareol
MDL No. :MFCD00869558
InChI Key :XVULBTBTFGYVRC-HHUCQEJWSA-N
Pubchem ID :163263

Safety of Sclareol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319
Precautionary Statements:P264-P280-P305+P351+P338+P337+P313

Isoform Comparison

Biological Activity

Description
Sclareol, obtained from Salvia sclarea, possesses anticarcinogenic potential and exhibits significant cytotoxicity against mouse leukemia (P-388) cells, human epidermal carcinoma (KB) cells, and human leukemia cell lines, primarily by inducing apoptosis[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
Arabidopsis plants 100 µM 24 hours Sclareol treatment induced AtPDR12 gene expression, increasing by 926-fold Plant Physiol. 2003 Nov;133(3):1272-84
HEK-293 cells 10 µM 48 hours Validate the response of CaB-A system to CCBs under KCl-mediated cell depolarization Adv Sci (Weinh). 2022 Mar;9(7):e2102855
Arabidopsis Col-0 wild-type plants 100 µM 48 hours To study the effect of sclareol on chlorophyll content, results showed that sclareol treatment significantly reduced chlorophyll content. Plants (Basel). 2023 Mar 11;12(6):1282

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Arabidopsis Col-0 wild-type Root soaking 100 μM 48 hours To study the effect of sclareol on endogenous compounds (e.g., campesterol and stigmasterol) in plants, results showed that sclareol treatment significantly increased the levels of these compounds. Plants (Basel). 2023 Mar 11;12(6):1282
Arabidopsis AtPDR12 insertion line Medium treatment 50-300 μM 3-6 days AtPDR12 insertion line showed reduced germination rates and significant inhibition of root elongation at 50 μM sclareol treatment Plant Physiol. 2003 Nov;133(3):1272-84
Mice 6-OHDA-induced Parkinson's disease model Intraperitoneal injection 55 mg/kg Once daily for 30 days Evaluate the neuroprotective effect of sclareol in a Parkinson's disease model Adv Sci (Weinh). 2022 Mar;9(7):e2102855

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.24mL

0.65mL

0.32mL

16.21mL

3.24mL

1.62mL

32.41mL

6.48mL

3.24mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories